Delivery Order SPE2DX22D0049-SPE2D825FA9FX
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $275,058.03 on April 23, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on April 24, 2025, and carries no set-aside designation. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,045.04 by the Defense Logistics Agency's Medical Supply Chain on August 17, 2025. This non-competitive delivery order represents a firm fixed price contract with an ultimate completion date of August 18, 2025, and is classified as a child contract under a larger indefinite delivery vehicle. The award demonstrates AmerisourceBergen's continued role...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $45,278.31 on July 28, 2025, by the Defense Logistics Agency's Medical Supply Chain with a completion date of July 29, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,355.40 by the Defense Logistics Agency's Medical Supply Chain on August 14, 2025. This firm fixed-price delivery order, which carries an ultimate completion date of August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $67,151.06 by the Defense Logistics Agency's Medical Supply Chain on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. This delivery order represents a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,447.93 on August 4, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $3,123.51 by the Defense Logistics Agency's Medical Supply Chain on August 27, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is scheduled for completion by August 28, 2025. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,107.62 under a Firm Fixed Price contract by the Defense Logistics Agency's Medical Supply Chain on July 29, 2025. The delivery order is classified as a child contract and carries an ultimate completion date of July 30, 2025. This award was competitively procured with no set-aside designation and represents a continuation of AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,646.92 by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D825FA9FXDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $57,029.60 by the Defense Logistics Agency's Medical Supply Chain. The contract, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. The delivery order falls within AmerisourceBergen's established role as a critical federal vendor supplying a broad spectrum of pharmaceutical products and medical supplies to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates expertise in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This competitively awarded contract reflects AmerisourceBergen's demonstrated capability to meet federal procurement requirements and supports the Defense Logistics Agency's strategic Pharmaceutical Prime Vendor Global Program initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $57.0k | 7/28/25 |